Showing results (81-90 of 298) with videos related to
Sort By:
Pageof 30
Frontiers in Bioscience : a Journal and Virtual Library|November 29, 2002
Liver fibrosis: signals leading to the amplification of the fibrogenic hepatic stellate cellErwin Gäbele, David A Brenner, Richard A RippeHepatology (Baltimore, Md.)|February 26, 2003
Genetic polymorphisms and the progression of liver fibrosis: a critical appraisalRamón Bataller, Kari E North, David A BrennerBlood|August 1, 2002
An exon 10 deletion in the mouse ferrochelatase gene has a dominant-negative effect and causes mild protoporphyriaScott T Magness, Nobuyo Maeda, David A BrennerDigestive Diseases (Basel, Switzerland)|March 2, 2006
Molecular mechanisms of alcohol-induced hepatic fibrosisSoren V Siegmund, Steven Dooley, David A BrennerAmerican Journal of Physiology. Gastrointestinal and Liver Physiology|June 28, 2003
Human hepatic stellate cells express CCR5 and RANTES to induce proliferation and migrationRobert F Schwabe, Ramon Bataller, David A BrennerSeminars in Liver Disease|February 14, 2007
Genomics of liver fibrosis and cirrhosisChristoph H Osterreicher, Felix Stickel, David A BrennerJournal of Clinical Gastroenterology|October 9, 2015
Role of Gut Microbiota in Liver DiseaseDavid A Brenner, Yong-Han Paik, Bernd SchnablHepatology (Baltimore, Md.)|August 5, 2010
CX3CL1-CX3CR1 interaction prevents carbon tetrachloride-induced liver inflammation and fibrosis in miceTomonori Aoyama, Sayaka Inokuchi, David A Brenner, et al.Hepatology (Baltimore, Md.)|July 28, 2006
Loss of MMP 13 attenuates murine hepatic injury and fibrosis during cholestasisHiroshi Uchinami, Ekihiro Seki, David A Brenner, et al.Gastroenterology Research and Practice|January 29, 2011
Role of toll-like receptors and their downstream molecules in the development of nonalcoholic Fatty liver diseaseKouichi Miura, Ekihiro Seki, Hirohide Ohnishi, et al.Pageof 30